• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二线基于左氧氟沙星的三联疗法对消化性溃疡患者根除幽门螺杆菌的疗效。

Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer.

作者信息

Ermis Fatih, Akyuz Filiz, Uyanikoglu Ahmet, Kurt Ramazan, Pinarbasi Binnur, Nazik Hasan, Kaymakoglu Sabahattin, Mungan Zeynel

机构信息

Department of Gastroenterology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

出版信息

South Med J. 2011 Aug;104(8):579-83. doi: 10.1097/SMJ.0b013e3182249be0.

DOI:10.1097/SMJ.0b013e3182249be0
PMID:21886067
Abstract

OBJECTIVES

First-line standard eradication efficacy with lansoprazole, amoxicillin and clarithromycin regressed over 10 years. The aim of this study was to evaluate the efficacy and tolerability of a levofloxacin-based regimen in patients with peptic ulcer after failure of the standard first-line H.pylori eradication therapy in a country with a high rate of infection.

METHODS

A total of 91 peptic ulcer patients who were diagnosed H.pylori positive proven by rapid urease test and histology between November 2005 to March 2008 were given lansoprazole 30 mg bid, amoxicillin 1 g bid and clarithromycin 500 mg bid (LAC) for 14 days. After three months from the first line eradication treatment omeprazole 20 mg bid, levofloxacin 500 mg bid, amoxicillin 1 g bid (OLA) 7 day treatment regimen was recommended as a second-line therapy for 37 patients who failed at first-line standard triple therapy.

RESULTS

Eradication rates for LAC regimen were found to be 57.14% (52/91) for intention to treat and 58.42% (52/89) for per protocol analysis. Eradication rates for OLA regimen were found to be 37.83% (14/37) for ITT and 41.17% (14/34) for PP analysis.

CONCLUSION

OLA regimen eradication rate was successful only in 40% of patients who failed in the first-line eradication. New eradication treatment strategies must be performed, at least in Turkey.

摘要

目的

兰索拉唑、阿莫西林和克拉霉素的一线标准根除疗效在10年间有所下降。本研究的目的是评估在一个感染率较高的国家,对于标准一线幽门螺杆菌根除治疗失败的消化性溃疡患者,基于左氧氟沙星的治疗方案的疗效和耐受性。

方法

2005年11月至2008年3月期间,共有91例经快速尿素酶试验和组织学检查确诊为幽门螺杆菌阳性的消化性溃疡患者,给予兰索拉唑30mg bid、阿莫西林1g bid和克拉霉素500mg bid(LAC)治疗14天。在一线根除治疗三个月后,对于37例一线标准三联疗法失败的患者,推荐使用奥美拉唑20mg bid、左氧氟沙星500mg bid、阿莫西林1g bid(OLA)的7天治疗方案作为二线治疗。

结果

LAC方案的意向性治疗根除率为57.14%(52/91),符合方案分析的根除率为58.42%(52/89)。OLA方案的意向性治疗根除率为37.83%(14/37),符合方案分析的根除率为41.17%(14/34)。

结论

OLA方案仅在40%的一线根除失败患者中取得成功。至少在土耳其,必须采用新的根除治疗策略。

相似文献

1
Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer.二线基于左氧氟沙星的三联疗法对消化性溃疡患者根除幽门螺杆菌的疗效。
South Med J. 2011 Aug;104(8):579-83. doi: 10.1097/SMJ.0b013e3182249be0.
2
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.二线左氧氟沙星治疗对幽门螺杆菌感染根除治疗失败后的疗效:西班牙 1000 例多中心研究的时间趋势。
J Clin Gastroenterol. 2013 Feb;47(2):130-5. doi: 10.1097/MCG.0b013e318254ebdd.
3
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.幽门螺杆菌治疗失败后使用左氧氟沙星进行二线挽救治疗:一项针对300名患者的西班牙多中心研究。
Am J Gastroenterol. 2008 Jan;103(1):71-6. doi: 10.1111/j.1572-0241.2007.01500.x. Epub 2007 Aug 31.
4
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.临床试验:克拉霉素对比左氧氟沙星一线三联及序贯疗法根除幽门螺杆菌。
Aliment Pharmacol Ther. 2010 May;31(10):1077-84. doi: 10.1111/j.1365-2036.2010.04274.x. Epub 2010 Feb 20.
5
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.奥美拉唑、阿莫西林和克拉霉素三联疗法治疗幽门螺杆菌感染消化性溃疡患者1周与2周的比较:一项随机对照试验的结果
J Gastroenterol. 1999;34 Suppl 11:76-9.
6
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.左氧氟沙星、克拉霉素和埃索美拉唑三联疗法作为中东地区幽门螺杆菌根除的一线治疗的疗效和安全性:前瞻性、随机、盲法、对照、多中心研究。
Eur J Intern Med. 2010 Aug;21(4):310-4. doi: 10.1016/j.ejim.2010.05.011. Epub 2010 Jun 16.
7
Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.四种不同治疗方案根除幽门螺杆菌的疗效和耐受性评估。
Panminerva Med. 1996 Sep;38(3):145-9.
8
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?兰索拉唑、阿莫西林和克拉霉素联合用药仍可作为根除幽门螺杆菌的一线治疗方案吗?
Turk J Gastroenterol. 2005 Mar;16(1):29-33.
9
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.在两次幽门螺杆菌治疗失败后使用左氧氟沙星进行三线挽救治疗。
Am J Gastroenterol. 2006 Feb;101(2):243-7. doi: 10.1111/j.1572-0241.2006.00457.x.
10
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.在日本消化性溃疡患者中,使用兰索拉唑、阿莫西林和克拉霉素三联疗法根除幽门螺杆菌的大规模多中心双盲研究的随访调查。
J Gastroenterol. 2003;38(4):339-47. doi: 10.1007/s005350300061.

引用本文的文献

1
Update on quinolone-containing rescue therapies for infection.感染的含喹诺酮类药物的挽救治疗的最新进展。
World J Gastroenterol. 2020 Apr 21;26(15):1733-1744. doi: 10.3748/wjg.v26.i15.1733.
2
Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.土耳其幽门螺杆菌根除的标准三联疗法:十年研究的系统评价与荟萃分析
Turk J Gastroenterol. 2019 May;30(5):420-435. doi: 10.5152/tjg.2019.18693.
3
Helicobacter pylori eradication in West Asia: a review.西亚地区幽门螺杆菌的根除:一项综述。
World J Gastroenterol. 2014 Aug 14;20(30):10355-67. doi: 10.3748/wjg.v20.i30.10355.
4
Rescue Therapy for Helicobacter pylori Infection 2012.2012 年幽门螺杆菌感染的挽救治疗。
Gastroenterol Res Pract. 2012;2012:974594. doi: 10.1155/2012/974594. Epub 2012 Feb 28.